Notes
Slide Show
Outline
1
Syndromic Surveillance in North Dakota: A gastrointestinal illness case study
  • Isaac Triebold*1, Margaret L. Khaitsa2 , Julie L. Goplin3, William Nganje4, Penelope Gibbs2, Neil W. Dyer5.
  • 1The Great Plains Institute of Food Safety, 2Department of Veterinary and Microbiological Sciences, 4Department of Agribusiness and Applied Economics, 5Department of Veterinary Diagnostic Services, North Dakota State University, Fargo, ND. 3North Dakota Department of Health, Bismarck, ND.
2
Introduction to Syndromic Surveillance
  • “An investigational approach where health department staff, assisted by automated data acquisition and generation of statistical alarms, monitor disease indicators in real-time or near real-time to detect outbreaks of diseases earlier than would otherwise be possible with traditional public health methods.”
    • -CDC
3
Introduction to Syndromic Surveillance
  • In North Dakota…
    • RedBat is the syndromic surveillance system that takes ER complaint data and categorizes symptoms into 11 syndromes
    • Data sent from ER to Department of Health
    • Each syndrome is assigned score correlating with the symptoms provided
      • High enough score is considered a case
      • Large amounts of similar syndrome cases will trigger alarm if they exceed CUSUM baseline
        • CUSUM (cumulative sum) is statistical method used to calculate deviations from the amount of disease expected
4
Introduction to Syndromic Surveillance
  • Syndromes analyzed by RedBat
    • Gastrointestinal illness
    • Encephalitis
    • Influenza-like illness
    • Hepatitis





    • Pulmonary
    • Radiation Sickness
    • Rash Illness
    • SARS
    • Sepsis
    • Systemic Disease
    • Neurologic Intoxication
5
 
6
 
7
Syndromic Surveillance Sites in ND
8
Objectives
  • Determine the effectiveness of syndromic surveillance in North Dakota using the retrospective case study
    • 1. Set appropriate baseline for GI illness syndrome
    • 2. Determine if syndromic surveillance would have helped in this case
    • 3. Estimate the economic potential of the system
9
Materials and Methods
  • Objective 1:
    • Use RedBat outputs to determine what the appropriate sensitivity would be for GI illness
  • Objective 2:
    • Assuming appropriate sensitivity was set, assess the response that would have occurred during the outbreak and if it would RedBat was operational
10
Materials and Methods
  • Objective 3:
    • Use real options model to estimate systems value
      • Use data from economic research service to estimate costs
        • Cost per case of E. coli 0157:H7
      • Estimate benefits by time saved in detection (prevention of cases and earlier treatment)
11
Background on Case Study
  • October 10, 2003 the NDDoH was notified of 4 cases of E. coli O157:H7 that had dined at the same restaurant
    • Exposure date of Sept. 30 or Oct. 1
    • 127 people interviewed with 13 cases
      • 5 lab confirmed, 8 met case definition
        • Case definition was anyone experiencing diarrhea 2-10 days after eating at the restaurant on exposure date
12
RedBat Output (7 Day Calculation)
13
RedBat Output (14 Day Calculation)
14
Results
  • The 7 day CUSUM calculation sets the appropriate level of sensitivity
    • Using the 7 day CUSUM calculation method RedBat signaled an outbreak Oct. 2 (8 day gain over the actual time NDDoH was notified)
      • The 14 day CUSUM calculation would probably have not recognized the outbreak
15
Results
  • Total cost of system estimated at $109,500 annually
    • Hardware & Software – $76,890
    • Labor – $24,940
    • Other Capital – $7,670
  • Average benefits per case of E. coli O157:H7 in case study $2,691
    • Based on average treatment cost and lost productivity for cases in study

16
Conclusion
  • Syndromic surveillance can be useful in early detection of naturally occurring outbreaks
  • It will be economically feasible, in the case of GI illness, if the time saved by using it reduces the number of cases
17
References
  • 1. Sosin, DM. Draft Framework for Evaluating Syndromic Surveillance Systems. Journal of Urban Health 2003; 80(2): i8-i13.
  • 2. Foldy SL. Linking Better Surveillance to Better Outcomes. In: Syndromic Surveillance: Reports from a National Conference, 2003. MMWR 2004; 53 (Suppl): 12-17.
  • 3. Burkom H, Elbert Y, Feldman A, Lin J. Role of Data Aggregation in Biosurveillance Detection Strategies with Applications from ESSENCE. In: Syndromic Surveillance: Reports from a National Conference, 2003. MMWR 2004; 53 (Suppl): 67-73.
  • 4. North Dakota Department of Health.  Syndromic Surveillance. Available from: http://www.health.state.nd.us/disease/Surveillance/syndromicsurveillance.htm
  • 5. Hutwagner L, Browne T, Seeman G, Fleischauer A. Comparing Aberration Detection Methods with Simulated Data. Emerg Infect Dis 2005; 2: 314-316.
    8. CDC Fact Sheet. Escherichia coli 0157:H7. December 2000. Available from http://www.cdc.gov/ncidod/dbmd/diseaseinfo/escherichiacoli_t.htm.